Ferring Pharmaceuticals Presents Two New Analyses of Pivotal Trial Data for Follitropin Delta (FE 999049) at ASRM 2025 ...
An enzyme in the blue blood has been key to testing vaccines since the 1980s, raising concerns for the crabs’ population. But ...
Abstract: Embedded Multi-die Interconnect Bridge (EMIB) packaging technology has been being widely adopted in Intel's FPGA, Server CPU, GPU, and data centric high-performance compute (HPC) segments ...
French dairy giant Bel Group and precision fermentation firm Standing Ovation have produced casein with dairy industry waste ...
Preclinical studies have shown CPV-104 to be functionally equivalent to endogenous human Factor H, with the ability to normalize serum C3 levels and promote clearance of pathogenic complement deposits ...
Vaxart to Present Research on Second-Generation Norovirus Oral Pill Vaccine Candidate at IDWeek 2025
Vaxart, Inc. (OTCQX: VXRT) (“Vaxart”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that it ...
As research becomes ever more sophisticated and regulatory requirements tighten, ProPure ™ is a game-changer for life science ...
Receiving a platform technology designation from the FDA is a tremendous milestone for our development team and Krystal, both as recognition of the reproducibility and scalability of our HSV-1 gene ...
The Trump administration has tightened its crackdown on Chinese tech firms by expanding export restrictions to include subsidiaries of companies already on the entity list. This move aims to close ...
Thinking about Micron Technology and wondering if it's time to buy, sell, or just sit tight? You’re not alone. The stock has been on an impressive run, leaving investors both excited and a little ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results